Abstract
Anaemia is one of leading health problems among children in The Gambia.1 Previous analysis suggests that the prevalence of anaemia among children in The Gambia will increase by approximately 1·2% between 2017 and 2025.2 In The Lancet Global Health, Rita Wegmüller and colleagues3 report the results of a individually randomised, three-arm, double-blind, non-inferiority trial. The aim of the study was to test two hepcidin-guided screen-and-treat regimens designed to reduce overall iron dosage by targeting administration to periods when the children were safe and ready to receive iron supplementation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
